CytRx (CYTR) to Present Statistically Significant Evidence of Arimoclomol's Ability to Protect Experimental Animals from Effects of Hypoxia
Tweet Send to a Friend
CytRx Corporation (NASDAQ: CYTR) announced that an experimental animal trial produced statistically significant evidence that the company's chaperone amplifying drug ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
